International Study to Predict Optimised Treatment - in Depression
- Status
- UNKNOWN
- Phase
- PHASE4
Clinical Trials Related to Major Depressive Disorder
Related studies linked through entity extraction aliases.
TC-5214 as add-on the Treatment of Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE2
Quetiapine in Co-Morbid Depressive and Anxiety Disorders
- Status
- COMPLETED
- Phase
- NA
A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Randomized, Double-Blind, Placebo Controlled Study of Vilazodone's Efficacy, Safety, and Biomarkers of Response in Major Depressive Disorder (MDD)
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Adults With Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Vortioxetine (Lu AA21004) in the Treatment of Patients With Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE3
Escitalopram in Adult Patients With Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of DOV 21,947 in the Treatment of Major Depressive Disorder
- Status
- TERMINATED
- Phase
- PHASE2
A One Year Open Label Study Assessing the Safety and Tolerability of Vilazodone in Patients With Major Depressive Disorder (MDD)
- Status
- COMPLETED
- Phase
- PHASE3
Time to Remission of Depressive Symptoms With Combined SSRI and Ramelteon
- Status
- TERMINATED
- Phase
- PHASE3
Randomised Placebo-controlled Duloxetine-referenced Efficacy and Safety Study of 2.5, 5 and 10 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE3
Ziprasidone Augmentation of SSRIs for Patients With Major Depressive Disorder (MDD) That do Not Sufficiently Respond to Treatment With SSRIs
- Status
- COMPLETED
- Phase
- PHASE2
Brain Mechanisms and Targeting Insomnia in Major Depression
- Status
- UNKNOWN
- Phase
- PHASE4
Safety and Effectiveness Study of BCI-540 Versus Placebo in the Treatment of Major Depressive Disorder With Concomitant Anxiety
- Status
- COMPLETED
- Phase
- PHASE2
Behavioral Insomnia Therapy For Those With Insomnia and Depression
- Status
- UNKNOWN
- Phase
- NA
Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Child And Adolescent Outpatients With Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE2
Duloxetine for the Treatment of Postpartum Depression
- Status
- WITHDRAWN
- Phase
- NA
Treatment of Mood and Marriage Study (TOMMS)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Brief Behavioral Therapy for Insomnia (bBT-I) for Depressed Outpatients With Refractory Insomnia
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3